Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine

References

• Allen J. R., Hsu I. C., Carstens L. A. Dehydroretronecine-induced rhabdomyosarcomas in rats. Cancer Research 1975; 35: 997–1002
   PubMed Web of Science ®Google Scholar
• Buhler D. R., Kedzierski B. Biological reactive intermediates of pyrrolizidine alkaloids. Biological Reactive Intermediates, J. J. Kocsis, D. J. Jollow, C. M. Witmer, J. O. Nelson, R. Snyder. Plenum, New York 1986; vol. III: 611–620
   Google Scholar
• Culvenor C. C. J., Edgar J. A., Smith L. W., Tweeddale H. J. Dihydropyrrolizines III. Preparation and reactions of derivatives related to pyrrolizidine alkaloids. Australian Journal of Chemistry 1970; 23: 1853–1867
   Web of Science ®Google Scholar
• Hirono I. Natural carcinogenic products of plant origin. CRC Critical Reviews in Toxicology 1981; 8: 235–266
   Web of Science ®Google Scholar
• Hoskins W. M., Crout D. H. G. Pyrrolizidine alkaloid analogues. Preparation of semisynthetic esters of retronecine. Journal of the Chemical Society Perkin Transactions I 1977; 538–544
   PubMedGoogle Scholar
• Hsu I. C., Robertson K. A., Shumaker R. C., Allen J. R. Binding of tritiated dehydroretronecine to macromolecules. Research Communications in Chemical Pathology and Pharmacology 1975; 11: 99–106
   PubMedGoogle Scholar
• Hsu I. C., Robertson K. A., Allen J. R. Tissue distribution, binding properties, and lesions produced by dehydroretronecine in the nonhuman primate. Chemico-Biological Interactions 1976; 12: 19–28
   PubMedGoogle Scholar
• Huxtable R. J. Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States. Perspectives in Biology and Medicine 1980; 24: 1–14
   PubMed Web of Science ®Google Scholar
• Huxtable R. J., Bowers R., Mattocks A. R., Michnicka M. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline. Biological Reactive Intermediates, vol. IV: Molecular and Cellular Effects and their impact on Human Health, C. M. Witmer, R. R. Snyder, D. J. Jollow, G. F. Kalf, J. J. Kocsis, I. G. Sipes. Plenum, New York 1990; 605–611
   Google Scholar
• Jago M. V., Edgar J. A., Smith L. W., Culvenor C. C. J. Metabolic conversion of heliotridine-based pyrrolizidine alkaloids to dehydroheliotridine. Molecular Pharmacology 1970; 6: 402–406
   PubMed Web of Science ®Google Scholar
• Karchesy J. J., Arbogast B., Deinzer M. L. Kinetics of alkylation reactions of pyrrolizidine alkaloid pyrroles. Journal of Organic Chemistry 1987; 52: 3867–3872
   Google Scholar
• Kedzierski B., Buhler D. R. Method for determination of pyrrolizidine alkaloids and their pyrrolizidine alkaloids. Toxicology Letters 1986; 25: 115–119
   Google Scholar
• Kedzierski B., Buhler D. R. Method for determination of pyrrolizidine alkaloids and their metabolites by high-performance liquid chromatography. Analytical Biochemistry 1986; 152: 59–65
   PubMed Web of Science ®Google Scholar
• Lafranconi W. M., Ohkuma S., Huxtable R. J. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline. Toxicon 1985; 23: 983–992
   PubMedGoogle Scholar
• Lame M. W., Morin D., Jones A. D., Segall H. J., Wilson D. W. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicology Letters 1990; 51: 321–329
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mattocks A. R. Chemistry and Toxicology of Pyrrolizidine Alkaloids. Academic Press, New York 1986
   Google Scholar
• Mattocks A. R., Bird I. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: Relevance to in vivo hepatotoxicity. Chemico-Biological Interactions 1983; 43: 209–222
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., Jukes R. Recovery of the pyrrolic nucleus of pyrrolizidine alkaloid metabolites from sulphur conjugates in tissues and body fluids. Chemico-Biological Interactions 1990a; 75: 225–239
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., Jukes R. Trapping and measurement of short-lived alkylating agents in a recirculating flow system. Chemico-Biological Interactions 1990b; 76: 19–30
   PubMedGoogle Scholar
• Mattocks A. R., White I. N. H. Conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizidine derivatives by rat-liver microsomes in vitro. Chemico-Biological Interactions 1971; 3: 383–391
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., Legg R. J., Jukes R. Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver. Toxicology Letters 1990; 54: 93–99
   PubMedGoogle Scholar
• Mattocks A. R., Croswell S., Jukes R., Huxtable R. J. Identity of a biliary metabolite formed from monocrotaline in isolated perfused rat liver. Toxicon 1991; 29: 409–415
   PubMed Web of Science ®Google Scholar
• McLean E. K. The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacological Reviews 1970; 22: 429–483
   PubMedGoogle Scholar
• Niwa H., Ogawa T., Okamoto O., Yamada K. Alkylation of nucleosides by dehydromono-crotaline, the putative toxic metabolite of the carcinogenic pyrrolizidine alkaloid monocrotaline. Tetrahedron Letters 1991; 32: 927–930
   Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Reed R. L., Buhler D. R. The synthesis of 3H-putrescine and subsequent biosynthesis of 3H-jacobine, a pyrrolizidine alkaloid from Senecio jacobaea. Journal of Labelled Compounds and Radiopharmaceuticals 1988; 25: 1041–1048
   Google Scholar
• Reed R. L., Ahern K. G., Pearson G. D., Buhler D. R. Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids. Corcinogenesis 1988; 9: 1355–1361
   PubMed Web of Science ®Google Scholar
• Robertson K. A. Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline. Cancer Research 1982; 42: 8–14
   PubMed Web of Science ®Google Scholar
• Robertson K. A., Seymour J. L., Hsia M. T., Allen J. R. Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione. Cancer Research 1977; 37: 3141–3144
   PubMed Web of Science ®Google Scholar
• Vamvakas S., Anders M. W. Formation of reactive intermediates by phase II enzymes: glutathione-dependent bioactivation reactions. Biological Reactive Intermediates, vol. IV: Molecular and Cellular Effects and their Impact on Human Health, C. M. Witmer, R. R. Snyder, D. J. Jollow, G. F. Kalf, J. J. Kocsis, I. G. Sipes. Plenum, New York, 13–24, White I. N. H. Mattocks A. R. 1971, Factors affecting the conversion of pyrrolizidine alkaloids to N-oxides and to pyrrolic derivatives in vitro. Xenobiotica 1991 1 503–505
   Google Scholar
• White I. N. H., Mattocks A. R. Reaction of dihydropyrrolidines with deoxyribonucleic acids in vitro. Biochemical Journal 1972; 128: 291–297
   PubMed Web of Science ®Google Scholar
• Wickramanayake P. P., Arbogast B. L., Buhler D. R., Deinzer M. L., Burlingame A. L. Alkylation of nucleosides and nucleotides by dehydroretronecine; characterization of covalent adducts by liquid secondary ion mass spectrometry. Journal of the American Chemical Society 1985; 107: 2485–2488
   Web of Science ®Google Scholar
• Williams D. E., Reed R. L., Kedzierski B., Dannan G. A., Guengerich F. P., Buhler D. R. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver. Drug Metabolism and Disposition 1989; 17: 387–392
   PubMed Web of Science ®Google Scholar